Ultragenyx Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage biopharmaceutical company. It is involved in the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company’s marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). Ultragenyx through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada and Mexico. The company is headquartered in Novato, California, the US.Scope
- Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Ultragenyx Pharmaceutical Inc.: Company Overview
- Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
- Ultragenyx Pharmaceutical Inc.: Overview
- Ultragenyx Pharmaceutical Inc.: Key Facts
- Ultragenyx Pharmaceutical Inc.: Key Employees
- Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
- Ultragenyx Pharmaceutical Inc.: Major Products and Services
- Ultragenyx Pharmaceutical Inc.: Management Statement
- Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
- Ultragenyx Pharmaceutical Inc.: Key Competitors
- Ultragenyx Pharmaceutical Inc.: Company Analysis
- Ultragenyx Pharmaceutical Inc.: Business Description
- Ultragenyx Pharmaceutical Inc.: SWOT Analysis
- Ultragenyx Pharmaceutical Inc.: SWOT Overview
- Ultragenyx Pharmaceutical Inc.: Strengths
- Ultragenyx Pharmaceutical Inc.: Weaknesses
- Ultragenyx Pharmaceutical Inc.: Opportunities
- Ultragenyx Pharmaceutical Inc.: Threats
- Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
- Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
- Ultragenyx Pharmaceutical Inc.: Targets and Partners
- Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
- Ultragenyx Pharmaceutical Inc.: Advisors
- Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
- Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
- Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
- Ultragenyx Pharmaceutical Inc.: Capital Raising
- Ultragenyx Pharmaceutical Inc.: Partnership
- Ultragenyx Pharmaceutical Inc.: Divestments
- Ultragenyx Pharmaceutical Inc.: Recent Developments
- Ultragenyx Pharmaceutical Inc.: News and Events Summary
- Ultragenyx Pharmaceutical Inc.: Business Expansion
- Ultragenyx Pharmaceutical Inc.: Corporate Governance
- Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
- Ultragenyx Pharmaceutical Inc.: Financial Performance
- Ultragenyx Pharmaceutical Inc.: Market Developments
- Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
- Ultragenyx Pharmaceutical Inc.: Research & Development
- Ultragenyx Pharmaceutical Inc.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
- Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
- Table 3: Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
- Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
- Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 7: Ultragenyx Pharmaceutical Inc.: Targets and Partners
- Table 8: Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
- Table 9: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
- Table 10: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
- Table 11: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 12: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
- Table 13: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 15: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 17: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Table 18: Ultragenyx Pharmaceutical Inc.: News and Events Summary
- Table 19: Ultragenyx Pharmaceutical Inc.: Business Expansion
- Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
- Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
- Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance
- Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments
- Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
- Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development
- Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and Operations
- Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
- Figure 5: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 6: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 7: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 8: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Figure 9: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
